Press Release: AbbVie : AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that new data from its early oncology research will be showcased across multiple presentations at the...
Read full article »
AbbVie is an Illinois-based biopharmaceutical company that develops and markets medicinal drugs for the treatment of neurodegenerative diseases and cancer.
Read more